Evidence map›Paper›PMID 32375488›Full record

ArticleEuropean heart journal. Acute cardiovascular care2020

Respiratory management in severe acute respiratory syndrome coronavirus 2 infection.

Susanna Price, Suveer Singh, Stephane Ledot, Paolo Bianchi, Matthew Hind, Guido Tavazzi, Pascal Vranckx

Open access · hybridAbstract read
In one paragraph

Article in European heart journal. Acute cardiovascular care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Observational
  7. Cardiovascular biomarkers in patients with COVID-19.European heart journal. Acute cardiovascular care · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Opportunities for biomaterials to address the challenges of COVID-19.Journal of biomedical materials research. Part A · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Susanna PriceAdult Intensive Care, Royal Brompton and Harefield NHS Foundation Trust, UK.
Suveer SinghAdult Intensive Care, Royal Brompton and Harefield NHS Foundation Trust, UK.
Stephane LedotAdult Intensive Care, Royal Brompton and Harefield NHS Foundation Trust, UK.
Paolo BianchiAdult Intensive Care, Royal Brompton and Harefield NHS Foundation Trust, UK.
Matthew HindDepartment of Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, UK.
Guido TavazziDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy.
Pascal VranckxDepartment of Cardiology and Intensive Care, Jessaziekenhuis Hasselt, Belgium.
Royal Brompton & Harefield NHS Foundation Trust · GBImperial College London · GBJessa Hospital · BEPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 pandemic is to date affecting more than a million of patients and is challenging healthcare professionals around the world. Coronavirus disease 2019 may present with a wide range of clinical spectrum and severity, including severe interstitial pneumonia with high prevalence of hypoxic respiratory failure requiring intensive care admission. There has been increasing sharing experience regarding the patient's clinical features over the last weeks which has underlined the need for general guidance on treatment strategies. We summarise the evidence existing in the literature of oxygen and positive pressure treatments in patients at different stages of respiratory failure and over the course of the disease, including environment and ethical issues related to the ongoing coronavirus disease 2019 infection.

Indexed as

BetacoronavirusCivil DefenseCoronavirus InfectionsCOVID-19Critical CareCross InfectionDisease ManagementExtracorporeal Membrane OxygenationFemaleHumansHypoxiaIdeal Body WeightIntubation, IntratrachealMaleOxygenPandemicsOxygenacute respiratory distress syndromecoronavirus disease 2019mechanical ventilationoxygen therapyrespiratory failureSevere acute respiratory syndrome coronavirus 2

Identifiers

PMID32375488
PMCPMC7215090
OpenAlexW3021093665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.